CD4 and neoplasm: In this study, there were not significant differences in the numbers or frequencies of immune or tumor cells between responders and non-responders; however, spatial analysis revealed that the distances between PD1+CD4+ T cells, tumor cells, and regulatory T cells, a population of dominant immune suppressors, predicted response to anti-PD-1 treatment.